{"id":"https://openalex.org/W4381378083","doi":"https://doi.org/10.2337/db23-70-lb","title":"70-LB: Tirzepatide Reduces the Predicted Risk of Developing Type 2 Diabetes\u2014Post Hoc Analysis of the SURMOUNT-1 Trial","display_name":"70-LB: Tirzepatide Reduces the Predicted Risk of Developing Type 2 Diabetes\u2014Post Hoc Analysis of the SURMOUNT-1 Trial","publication_year":2023,"publication_date":"2023-06-20","ids":{"openalex":"https://openalex.org/W4381378083","doi":"https://doi.org/10.2337/db23-70-lb"},"language":"en","primary_location":{"id":"doi:10.2337/db23-70-lb","doi":"https://doi.org/10.2337/db23-70-lb","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db23-70-lb","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053784299","display_name":"Emily R. Hankosky","orcid":"https://orcid.org/0000-0001-9934-584X","observed_orcids":["https://orcid.org/0000-0001-9934-584X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"EMILY R. HANKOSKY","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102892699","display_name":"HUI WANG","orcid":"https://orcid.org/0000-0003-2434-1419","observed_orcids":["https://orcid.org/0000-0003-2434-1419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HUI WANG","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010312288","display_name":"Lisa M. Neff","orcid":"https://orcid.org/0000-0002-3006-6057","observed_orcids":["https://orcid.org/0000-0002-3006-6057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LISA M. NEFF","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"HONGJUN KAN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HONGJUN KAN","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"FANGYU WANG","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FANGYU WANG","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056385953","display_name":"Nadia Y. Ahmad","orcid":"https://orcid.org/0000-0003-3607-0740","observed_orcids":["https://orcid.org/0000-0003-3607-0740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"NADIA AHMAD","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103095220","display_name":"Adam Stefa\u0144ski","orcid":"https://orcid.org/0009-0001-7598-402X","observed_orcids":["https://orcid.org/0009-0001-7598-402X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ADAM STEFANSKI","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038221659","display_name":"William Timothy Garvey","orcid":"https://orcid.org/0000-0003-0822-0860","observed_orcids":["https://orcid.org/0000-0003-0822-0860","https://orcid.org/0000-0001-8963-1412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. TIMOTHY GARVEY","raw_affiliation_strings":["Indianapolis, IN, King of Prussia, PA, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indianapolis, IN, King of Prussia, PA, Birmingham, AL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4112,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.64131419,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"72","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6948000192642212,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6948000192642212,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.2621999979019165,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.9309999942779541},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.7390000224113464},{"id":"https://openalex.org/keywords/overweight","display_name":"overweight","score":0.9200000166893005},{"id":"https://openalex.org/keywords/predictive-modeling","display_name":"predictive modeling","score":0.6740000247955322},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7919999957084656},{"id":"https://openalex.org/keywords/gip-receptor-agonist","display_name":"GIP receptor agonist","score":0.7680000066757202},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.453000009059906},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.4000000059604645},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.4269999861717224},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.5669999718666077},{"id":"https://openalex.org/keywords/post-hoc-analysis","display_name":"post hoc analysis","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.8249380588531494},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8188177347183228},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.6749175190925598},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6538585424423218},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6422320008277893},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.5395352840423584},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5349695682525635},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.46726030111312866},{"id":"https://openalex.org/C120195587","wikidata":"https://www.wikidata.org/wiki/Q2138790","display_name":"Absolute risk reduction","level":3,"score":0.46203047037124634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4539993107318878},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42120468616485596},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.4136478304862976},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.3284825384616852},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18066075444221497},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.09918951988220215},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db23-70-lb","doi":"https://doi.org/10.2337/db23-70-lb","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db23-70-lb","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4381378003","https://openalex.org/W4386705316","https://openalex.org/W4410177424","https://openalex.org/W4414618753","https://openalex.org/W4411915291","https://openalex.org/W4404310616","https://openalex.org/W7202131266","https://openalex.org/W7202101025","https://openalex.org/W7165341229","https://openalex.org/W4413356805"],"abstract_inverted_index":{"Background:":[0],"The":[1],"effect":[2],"of":[3,9,29,56,93,189,228,235],"tirzepatide":[4],"(TZP)":[5],"on":[6,32],"the":[7,27,36,61,159,224,236],"risk":[8,34,54,66,75,112,126,162,187,201,227,240],"developing":[10,229],"type":[11],"2":[12],"diabetes":[13],"(T2D)":[14],"in":[15,35,198,238],"people":[16],"with":[17,220],"obesity":[18],"or":[19],"overweight":[20],"is":[21],"unknown.":[22],"We":[23],"aimed":[24],"to":[25,60,64,81,99,184,232],"assess":[26],"impact":[28],"TZP":[30,100,129,173,204,221],"treatment":[31],"T2D":[33,230],"Phase":[37],"3":[38],"SURMOUNT-1":[39,62],"trial":[40,63],"through":[41],"predictive":[42],"modelling.":[43],"Methods:":[44],"Cardiometabolic":[45],"Disease":[46],"Staging,":[47],"a":[48,87],"validated":[49],"robust":[50],"tool":[51],"providing":[52],"10-year":[53,225],"estimates":[55],"T2D,":[57],"was":[58,241],"applied":[59],"derive":[65],"scores":[67,76,113,127],"at":[68,114,143,152],"baseline,":[69],"24,":[70],"and":[71,77,103,119,134,141,146,150,170,180,193,253,259,270,279,286,291,301,308,319,338,347],"72":[72,83],"weeks.":[73],"Mean":[74,111,125],"change":[78],"from":[79,86,117,164],"baseline":[80,115,165],"week":[82,144,153,157,244],"were":[84,96,137,166],"calculated":[85],"mixed":[88],"model.":[89],"Results:":[90],"A":[91],"total":[92],"2539":[94],"participants":[95],"randomized":[97],"1:1:1:1":[98],"5/10/15":[101],"mg":[102],"placebo":[104],"(PBO)":[105],"(mean":[106],"age=45":[107],"years;":[108],"female=68%;":[109],"White=71%).":[110],"ranged":[116],"23-24%":[118],"did":[120],"not":[121],"differ":[122],"between":[123,203],"groups.":[124],"for":[128,172],"5,":[130],"10,":[131],"15":[132,178,214],"mg,":[133,175,177,179],"PBO":[135,181,207],"groups":[136,205],"13%,":[138],"11%,":[139,140,147],"21%":[142],"24":[145],"9%,":[148,149],"23%":[151],"72,":[154,158],"respectively.":[155,195],"At":[156],"absolute":[160],"mean":[161],"reductions":[163,188],"12%,":[167,210],"14%,":[168,213],"15%,":[169],"1%":[171],"5":[174],"10":[176,211],"groups,":[182],"corresponding":[183],"median":[185],"relative":[186],"-60.3%,":[190],"-68.3%,":[191],"-69%,":[192],"-10.8%,":[194],"This":[196],"resulted":[197],"significantly":[199,222],"greater":[200],"reduction":[202,237],"vs.":[206],"(5":[208],"mg:":[209,212,215],"14%;":[216],"p<0.001).":[217],"Conclusion:":[218],"Treatment":[219],"reduced":[223],"predicted":[226,239],"compared":[231],"PBO;":[233],"most":[234],"achieved":[242],"by":[243],"24.":[245],"Disclosure":[246],"E.":[247],"R.":[248],"Hankosky:":[249],"Employee;":[250,267,283,298,305],"Eli":[251,257,268,277,284,289,299,306,317,336,345],"Lilly":[252,258,269,278,285,290,300,307,318,337,346],"Company,":[254,271,287,320,339],"Other":[255],"Relationship;":[256],"Company.":[260,280,292,302,309],"H.":[261,281],"Wang:":[262,294],"None.":[263,295],"L.":[264],"M.":[265],"Neff:":[266],"Research":[272,332],"Support;":[273,333],"Aegerion":[274],"Pharmaceuticals,":[275,326],"Stock/Shareholder;":[276,288],"Kan:":[282],"F.":[293],"N.":[296],"Ahmad:":[297],"A.":[303],"Stefanski:":[304],"W.":[310],"Garvey:":[311],"Advisory":[312],"Panel;":[313],"Boehringer-Ingelheim,":[314],"Novo":[315,334],"Nordisk,":[316,335],"Merck":[321],"&":[322],"Co.,":[323],"Inc.,":[324,327,330,342],"Alnylam":[325],"Fractyl":[328],"Health,":[329],"Inogen,":[331],"Epitomee,":[340],"Pfizer":[341],"Neurovalens.":[343],"Funding":[344],"Company":[348]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-06-21T00:00:00"}